Superinfection in malaria: Plasmodium shows its iron will

EMBO Reports

Volumn 12, Issue 12, 2011, Pages 1233-1242

  Portugal, Sílvia ^a   Drakesmith, Hal ^b   Mota, Maria M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

hepcidin; host pathogen interactions; immunity; infection; liver

Indexed keywords

HEPCIDIN; IRON;

ADAPTIVE IMMUNITY; ANEMIA; ANOPHELES; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; INFECTION RISK; INSECT BITE; LIVER CELL; MALARIA; MALARIA CONTROL; MEROZOITE; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RECURRENCE RISK; REINFECTION; REVIEW; SPOROZOITE; SUPERINFECTION;

HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY; IRON; MALARIA; PLASMODIUM; SUPERINFECTION;

EID: 82555176482     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2011.213     Document Type: Review

References (92)

1. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912 (Pubitemid 30441595)
2. Al-Yaman F, Genton B, Reeder JC, Anders RF, Smith T, Alpers MP (1997) Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans R Soc Trop Med Hyg 91: 602-605 (Pubitemid 27478660)
3. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H (2011) Hepcidin regulation by innate immune and infectious stimuli. Blood 118: 4129-4139
4. Babiker HA, Creasey AM, Bayoumi RA, Walliker D, Arnot DE (1991) Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 2. Drug resistance, molecular karyotypes and the mdr1 genotype of recent isolates. Trans R Soc Trop Med Hyg 85: 578-583
5. Beier MS, Schwartz IK, Beier JC, Perkins PV, Onyango F, Koros JK, Campbell GH, Andrysiak PM, Brandling-Bennett AD (1988) Identification of malaria species by ELISA in sporozoite and oocyst infected Anopheles from western Kenya. Am J Trop Med Hyg 39: 323-327
6. Belnoue E et al (2008) Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 181: 8552-8558
7. Boelaert JR, Vandecasteele SJ, Appelberg R, Gordeuk VR (2007) The effect of the host's iron status on tuberculosis. J Infect Dis 195: 1745-1753 (Pubitemid 46870246)
8. Boraschi D et al (2008) Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis 2: e255
9. Boyd MF (1939) Consecutive inoculations with Plasmodium vivax and Plasmodium falciparum. Am J Trop Med Hyg 1: 10
10. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361: 669-673 (Pubitemid 36246550)
11. Bruce MC, Day KP (2003) Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. Trends Parasitol 19: 271-277 (Pubitemid 36638729)
12. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP (2000) Cross-species interactions between malaria parasites in humans. Science 287: 845-848 (Pubitemid 30084325)
13. Bunnag D, Poltera AA, Viravan C, Looareesuwan S, Harinasuta KT, Schindlery C (1992) Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Trop 52: 59-67
14. Byrd T F, Horwitz MA (1991) Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest 88: 351-357
15. Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M, Tsafack A (1996) Iron chelators: mode of action as antimalarials. Acta Haematologica 95: 70-77 (Pubitemid 26071433)
16. Casals-Pascual C et al (2006) Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108: 2569-2577
17. Chlosta S, Fishman DS, Harrington L, Johnson EE, Knutson MD, Wessling-Resnick M, Cherayil BJ (2006) The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun 74: 3065-3067 (Pubitemid 43673024)
18. Clyde DF (1975) Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 24: 397-401
19. de Mast Q et al (2009a) Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 199: 253-262
20. De Mast Q et al (2009b) Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 145: 657-664
21. De Mast Q, Syafruddin D, Keijmel S, Olde Riekerink T, Deky O, Asih PB, Swinkels DW, van der Ven AJ (2010) Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 95: 1068-1074
22. De Monye C, Karcher DS, Boelaert JR, Gordeuk VR (1999) Bone marrow macrophage iron grade and survival of HIV-seropositive patients. Aids 13: 375-380 (Pubitemid 29095100)
23. Dicko A et al (2011) Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial. PLoS ONE 6: e23390
24. Donovan A et al (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781 (Pubitemid 30111839)
25. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1: 191-200 (Pubitemid 43960600)
26. Doolan DL, Dobano C, Baird JK (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36
27. Drakesmith H, Prentice A (2008) Viral infection and iron metabolism. Nat Rev Microbiol 6: 541-552 (Pubitemid 351863367)
28. Drakesmith H et al (2005) Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106: 1092-1097 (Pubitemid 41076459)
29. Finberg KE et al (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40: 569-571 (Pubitemid 351601217)
30. Fritsch G, Treumer J, Spira DT, Jung A (1985) Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol 60: 171-174 (Pubitemid 15239563)
31. Ganz T, Nemeth E (2011) Hepcidin and disorders of iron metabolism. Annu Rev Med 62: 347-360
32. Gardenghi S et al (2010) Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. J Clin Invest 120: 4466-4477
33. Garnham PC (1949) Malarial immunity in Africans; effects in infancy and early childhood. Ann Trop Med Parasitol 43: 47-61
34. Glickstein H, Breuer W, Loyevsky M, Konijn AM, Shanzer A, Cabantchik ZI (1996) Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells. Blood 87: 4871-4878 (Pubitemid 26162391)
35. Goma J, Renia L, Miltgen F, Mazier D (1995) Effects of iron deficiency on the hepatic development of Plasmodium yoelii. Parasite 2: 351-356
36. Goma J, Renia L, Miltgen F, Mazier D (1996) Iron overload increases hepatic development of Plasmodium yoelii in mice. Parasitology 112: 165-168 (Pubitemid 26069942)
37. Gordeuk VR, Thuma PE, Brittenham GM, Zulu S, Simwanza G, Mhangu A, Flesch G, Parry D (1992a) Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 79: 308-312
38. Gordeuk V et al (1992b) Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 327: 1473-1477
39. Graham SM, Walsh AL, Molyneux EM, Phiri AJ, Molyneux ME (2000) Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med H 94: 310-314 (Pubitemid 30406567)
40. Howard CT, McKakpo US, Quakyi IA, Bosompem KM, Addison EA, Sun K, Sullivan D, Semba RD (2007) Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg 77: 623-626 (Pubitemid 351844281)
41. Ives A et al (2011) Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331: 775-778
42. Konate AT et al (2011) Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS ONE 6: e23391
43. Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ (2007) Malarial anemia: of mice and men. Blood 110: 18-28 (Pubitemid 47026814)
44. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T (1987) High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 2: 1052-1055
45. Lorenzetti A et al (2008) Mixed Plasmodium falciparum infections and its clinical implications in four areas of the Brazilian Amazon region. Acta Trop 107: 8-12 (Pubitemid 351778153)
46. Loyevsky M, Sacci JB Jr, Boehme P, Weglicki W, John C, Gordeuk VR (1999) Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures. Exp Parasitol 91: 105-114 (Pubitemid 29370086)
47. Mabey DC, Brown A, Greenwood BM (1987) Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis 155: 1319-1321 (Pubitemid 17080512)
48. Mackenzie G et al (2010) A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS ONE 5: e10568
49. MalERA (2011) A research agenda for malaria eradication: basic science and enabling technologies. PLoS Med 8: e1000399
50. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60
51. Mayor A, Saute F, Aponte JJ, Almeda J, Gomez-Olive FX, Dgedge M, Alonso PL (2003) Plasmodium falciparum multiple infections in Mozambique, its relation to other malariological indices and to prospective risk of malaria morbidity. Trop Med Int Health 8: 3-11 (Pubitemid 36151570)
52. McKenzie FE, Bossert WH (1997) Mixed-species Plasmodium infections of humans. J Parasitol 83: 593-600 (Pubitemid 27357507)
53. McKie AT et al (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309 (Pubitemid 30628088)
54. Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y (1993) Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 37: 1108-1114 (Pubitemid 23141328)
55. Molineaux L, Gramiccia G (1980) The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. Geneva, Switzerland: World Health Organization
56. Murray MJ, Murray NJ, Murray AB, Murray MB (1975) Refeeding-malaria and hyperferraemia. Lancet 1: 653-654
57. Nairz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, Weiss G (2007) The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 9: 2126-2140 (Pubitemid 47250286)
58. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093 (Pubitemid 40007660)
59. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276 (Pubitemid 39069926)
60. Ocana-Morgner C, Mota MM, Rodriguez A (2003) Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 197: 143-151 (Pubitemid 36152309)
61. Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW (2009) Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malaria J 8: 4
62. Owusu-Agyei S, Smith T, Beck HP, Amenga-Etego L, Felger I (2002) Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health 7: 421-428 (Pubitemid 34535559)
63. Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139: 393-408; e391-e392
64. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819
65. Pollack S, Rossan RN, Davidson DE, Escajadillo A (1987) Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc Soc Exp Biol Med 184: 162-164 (Pubitemid 17022088)
66. Portugal S et al (2011) Host-mediated regulation of superinfection in malaria. Nat Med 17: 732-737
67. Pradines B et al (2006) In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother 57: 1093-1099 (Pubitemid 44644410)
68. Prentice AM, Ghattas H, Doherty C, Cox SE (2007) Iron metabolism and malaria. Food Nutr Bull 28: S524-S539 (Pubitemid 351149503)
69. Prudencio M, Rodriguez A, Mota MM (2006) The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4: 849-856 (Pubitemid 44593951)
70. Raventos-Suarez C, Pollack S, Nagel RL (1982) Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 31: 919-922 (Pubitemid 12030521)
71. Rencricca NJ, Stout JP, Coleman RM (1974) Erythropoietin production in virulent malaria. Infect Immun 10: 831-833
72. Richie TL (1988) Interactions between malaria parasites infecting the same vertebrate host. Parasitology 96: 607-639 (Pubitemid 19322306)
73. Robert V, Macintyre K, Keating J, Trape JF, Duchemin JB, Warren M, Beier JC (2003) Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg 68: 169-176 (Pubitemid 38240541)
74. Roestenberg M et al (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468-477
75. Roestenberg M et al (2011) Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377: 1770-1776
76. Rotheneder A, Fritsche G, Heinisch L, Mollmann U, Heggemann S, Larcher C, Weiss G (2002) Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes. Antimicrob Agents Chemother 46: 2010-2013 (Pubitemid 34535234)
77. Roux CM, Butler BP, Chau JY, Paixao TA, Cheung KW, Santos RL, Luckhart S, Tsolis RM (2010) Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to nontyphoidal Salmonella enterica serovar typhimurium infection in mice. Infect Immun 78: 1520-1527
78. Sama W, Owusu-Agyei S, Felger I, Dietz K, Smith T (2006) Age and seasonal variation in the transition rates and detectability of Plasmodium falciparum malaria. Parasitology 132: 13-21 (Pubitemid 43053656)
79. Sazawal S et al (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367: 133-143 (Pubitemid 43077129)
80. Schaible UE, Kaufmann SH (2004) Iron and microbial infection. Nat Rev Microbiol 2: 946-953 (Pubitemid 39562533)
81. Scheibel LW, Adler A (1980) Antimalarial activity of selected aromatic chelators. Mol Pharmacol 18: 320-325 (Pubitemid 10009418)
82. Scheibel LW, Adler A (1981) Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides. Mol Pharmacol 20: 218-223 (Pubitemid 11042437)
83. Scheibel LW, Adler A (1982) Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5: 6 by an aromatic ring. Mol Pharmacol 22: 140-144 (Pubitemid 12097274)
84. Snounou G, White NJ (2004) The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333-339 (Pubitemid 38749077)
85. Snow RW, Marsh K (2002) The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 52: 235-264 (Pubitemid 36069925)
86. Tanno T et al (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096-1101 (Pubitemid 47517510)
87. Thuma PE et al (1998a) Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med H 92: 214-218 (Pubitemid 28200806)
88. Thuma PE et al (1998b) Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Am J Trop Med Hyg 58: 358-364 (Pubitemid 28160761)
89. Vekemans J, Leach A, Cohen J (2009) Development of the RTS, S/AS malaria candidate vaccine. Vaccine 27 (Suppl 6): G67-G71
90. Waters AP, Mota MM, van Dijk MR, Janse CJ (2005) Parasitology. Malaria vaccines: back to the future? Science 307: 528-530 (Pubitemid 40165667)
91. Weinberg ED, Moon J (2009) Malaria and iron: history and review. Drug Metab Rev 41: 644-662
92. WHO (2010) World Malaria Report 2010. Geneva, Switzerland: World Health Organization Wijesundera Mde S (1988) Malaria outbreaks in new foci in Sri Lanka. Parasitol Today 4: 147-150